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The type I interferon system is essential for antiviral
immune response and is a primary target of viral im-
mune evasion strategies. Here, we show that virus
infection induces the expression of MAPK phos-
phatase 5 (MKP5), a dual-specificity phosphatase
(DUSP), in host cells. Mice deficient in MKP5 were
resistant to H1N1 influenza infection, which is associ-
ated with increased IRF3 activation and type I inter-
feron expression in comparison with WT mice.
Increased type I interferon responses were also
observed in MKP5-deficient cells and animals upon
other RNA virus infection, including vesicular stoma-
titis virus and sendai virus. These observations were
attributed to the ability of MKP5 to interact with and
dephosphorylate IRF3. Our study reveals a critical
function of a DUSP in negative regulation of IRF3 ac-
tivity and demonstrates a mechanism by which influ-
enza and other RNA viruses inhibit type I interferon
response in the host through MKP5.INTRODUCTION
Influenza viruses are respiratory pathogens that pose a major
burden to global health and consistently pose risk of epidemic
and pandemic outbreaks by newly emerged strains with the
most recent example being the emergence of H7N9 influenza
strain in China (Li et al., 2013). Influenza viruses are negative-
stranded RNA viruses classified as influenza A, B, and C types
(Julkunen et al., 2001). Type A influenza viruses are the most
pathogenic for humans and are responsible for both pandemic
and seasonal flu. Influenza virus generally invades and replicates1722 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Authorwithin epithelial cells but is also capable of infecting macro-
phages and other leukocytes as well (Hofmann et al., 1997; Jul-
kunen et al., 2001). Newly emerging influenza A strains pose a
significant public health challenge due to potential lack of herd
immunity in human population and their potential for resistance
to current antiviral therapeutics.
The innate immune system is the first line of defense against
influenza and other viral infection. Upon infection, influenza sin-
gle-stranded RNA can be recognized by the cytoplasmic RNA
helicase retinoic acid-inducible gene-I (RIG-I) (Pichlmair et al.,
2006) or by Toll-like receptor 7 (TLR7) in the endocytic compart-
ment (Diebold et al., 2004) to activate antiviral responses in
innate cells. Cytokines such as interleukin-6 (IL-6), tumor necro-
sis factor-alpha (TNF-a), type I interferons (IFNs), including IFNa
and IFNb, as well as chemokines like IL-8 are produced by
various cell types in the lung upon influenza infection. These cy-
tokines are critical for the initiation of immune responses impor-
tant to control virus replication and activate the adaptive immune
response (Julkunen et al., 2001; Michaelis et al., 2009). Type I
IFNs are crucial in limiting viral replication and mounting a robust
host immune responses against the infection (Gonza´lez-Navajas
et al., 2012; Sadler and Williams, 2008). Type I IFNs trigger a
multitude of events to inhibit viral replication, such as promoting
apoptosis of infected cells, inhibiting protein synthesis to inhibit
viral replication, and inducing transcription of many genes,
collectively termed interferon-stimulated genes (ISGs), which
work in synergy to inhibit viral replication (Gonza´lez-Navajas
et al., 2012; Sadler and Williams, 2008).
RIG-I and TLR7 serves as intracellular receptors for pathogens
such as influenza virus, vesicular stomatitis virus (VSV), and sen-
dai virus (SeV). TLR7 and RIG-I signal throughMyD88 andMAVS
(also called as VISA, Cardiff, and IPS-1), respectively, to activate
various transcriptional factors, including MAP kinases (MAPKs),
nuclear factor-kB (NF-kB), IFN regulatory factor 3 (IRF3), and
IRF7 to regulate the expression of genes, including type I IFNss
(Diebold et al., 2004; Kawai et al., 2005; Pichlmair et al., 2006;
Tamura et al., 2008). IRF3 is phosphorylated by the kinases
TANK-binding kinases 1 (TBK1) and inhibitor of kB kinase ε
(IKKε), which leads to its nuclear translocation and subsequent
regulation of expression of type I IFNs in response to virus infec-
tion (Kawai and Akira, 2008). It is believed that IRF3 or IRF3-IRF7
dimers work concomitantly with other transcriptional factors,
including NF-kB and ATF2/c-Jun, to form an enhanceosome
for IFNb gene transcription (Sato et al., 2000; Zhong et al.,
2008). The increased susceptibility to viral infection of the
IRF3-deficient mice and the impaired production of type I IFNs
by IRF3-deficient cells upon viral infection demonstrates the
essential role of IRF3 in regulating type I IFN expression (Sato
et al., 2000).
MAPKs play critical roles in regulating the expression of
various proinflammatory cytokines, including IL-6 and TNF-a in
response to microbial infection. The magnitude and duration of
MAPK activation in immune responses are controlled by the
MAPK phosphatases (MKPs), which are also known as dual-
specificity phosphatases (DUSPs) (Liu et al., 2007). Previous
work has demonstrated that MKPs/DUSPs are specifically
involved in the immune response against influenza infection,
where ablation of the MKP1 gene prevents viral clearance.
Mechanistically, ablation of MKP1 led to defective CD8+ T cell
activation and effector function important for virus clearance
(Zhang et al., 2009b). There is also evidence that type I IFN
expression may be regulated by MKPs. IFNb expression was
increased in MKP5 KO macrophages compared with WT cells
in response to LPS (Zhang et al., 2004). Overexpression of
MKP2 and MKP5 inhibited IFNb promoter activity in response
to LPS or poly (I:C) stimulation (McCoy et al., 2008). However,
how MKPs/DUSPs regulate type I IFN expression in vivo in
response to microbial infection is unclear.
In this study, we investigated the regulation of immune re-
sponses to RNA virus infection by MKP5. We demonstrate that
the deficiency of MKP5 results in reduced influenza virus replica-
tion in the lung, which is associated with increased type I IFN
production. We further observed increased IRF3-type I IFN re-
sponses in MKP5 KO cells/animals in response to VSV and
SeV. Importantly, we found that MKP5 inhibits IRF3 phosphory-
lation in a mechanism that leads to reduced IRF3 nuclear accu-
mulation to downregulation of type I IFN expression. Overall, our
findings provide a mechanism that viruses may utilize to evade
host immunity where MKP5 may represent a viable target for
new therapeutics aimed at eradicating RNA viruses.
RESULTS
Reduced Influenza Virus Replication and IncreasedType
I IFN Expression in the Lung of MKP5 KO Mice upon
Influenza Infection
To examine the possible involvement of MKP5 in immune
response to influenza virus infection, mouse bone-marrow-
derived macrophages (BMDMs) were infected with A/Puerto
Rico/8/34 (PR8, H1N1) and A/Aichi/2/68 (H3N2) viruses. We
found that the mRNA expression of MKP5 was significantly
increased in BMDMs in response to both H1N1 and H3N2 virus
infection (Figures 1A and S1A), and MKP5 protein expressionCellwas induced optimally at 3-hr post-infection (P.I.) (Figures 1B
and S1A). Thus, to further examine the function ofMKP5 in innate
immune responses against influenza infection, WT and MKP5
KOmice were infected with PR8 virus by intranasal (i.n.) inocula-
tion. We found that the viral titers in the lung of MKP5 KO mice
were significantly lower compared with WT mice on days 2, 3,
and 5 P.I. (Figure 1C), indicating that deficiency of MKP5 resulted
in reduced viral replication. We next analyzed IFNb, an essential
component of host antiviral defense (Gonza´lez-Navajas et al.,
2012; Sadler andWilliams, 2008). We found that IFNb production
in the bronchoalveolar lavage (BAL) andmRNA expression in the
lung fromMKP5 KOmice were significantly increased on days 2,
3, and 5 P.I. compared withWTmice (Figure 1D). The concentra-
tions of IFNa and IL-6 were increased in the homogenates of
lungs from MKP5 KO mice as well, whereas TNF-a expression
was comparable (Figure 1E). We also found increased expres-
sion of IFNa and IFNb in the lung from MKP5 knockout (KO)
mice upon H3N2 virus infection compared with WT mice
(Figure S1B).
Influenza virus infection leads to massive infiltration of immune
cells which contribute to inflammation, activation of immune re-
sponses, aswell as lung injury (Maines et al., 2008; Perrone et al.,
2008). However, total infiltrated cell numbers in the lung were
comparable between WT and KO mice (Figure S1C). The per-
centages of the neutrophils, macrophages, and dendritic cells
(DCs) were comparable aswell (Figures S1D andS1E), indicating
that the increased total IFNa and IFNb levels in the lung of MKP5
KO mice were due to enhanced expression of IFNa and IFNb on
a per cell basis.
IRF3 is essential for the expression of type I IFNs. Therefore,
we examined the activation of IRF3 in the lung from WT and
KO mice on day 3 P.I. Increased IRF3 activation was observed
in KO lungs compared with WT lungs (Figure 1F). Furthermore,
significantly increased expression of the ISGs, ISG-15, 20-50-
oligo (A) synthetase (OAS), RANTES/CCL5, and viperin, was
found in the lungs from KO as well (Figure 1G). Conversely, the
expression of viral-specific protein polymerase 2 (PB2) was
decreased in the lungs from KOmice (Figure 1F). Therefore, defi-
ciency of MKP5 resulted in increased IRF3 activation and type I
IFN expression in the lung, which is associated with decreased
viral replication in response to influenza infection compared
with WT mice.
Deficiency of MKP5 Results in Reduced Disease
Severity upon Influenza Infection
To determine the impact of the MKP5 deficiency and enhanced
type I IFN expression on influenza pathogenicity, we infectedWT
and MKP5 KO mice with a sublethal dose of PR8 virus. Both WT
and KOmice started to lose weight on day 5 P.I. and reached the
maximum weight loss on day 9 P.I. followed by recovery (Fig-
ure 1H). However, MKP5 KO mice exhibited substantially less
weight loss compared with WT counterparts. Moreover, the
expression of HA and NA genes was significantly lower in the
lung of KO mice on day 11 P.I. compared with WT mice (Fig-
ure S1F), indicating that deficiency of MKP5 resulted in
enhanced viral clearance. To determine the impact of MKP5
deficiency on adaptive immune response, influenza-specific
CD4+ and CD8+ cells from the lung were analyzed usingReports 10, 1722–1734, March 17, 2015 ª2015 The Authors 1723
Figure 1. Deficiency of MKP5 Inhibited Influenza Virus Replication in the Lung
(A) BMDMs were infection with or without H1N1 (PR8) influenza virus, and MKP5 expression was determined by quantitative real-time PCR (qPCR).
(B) MKP5 protein expression in BMDMs upon PR8 infection was determined by western blot analysis.
(C) Viral titers in the lung of MKP5 WT and KO mice (four to five mice per group) on days 2, 3, and 5 P.I. were determined by plaque assay.
(D) Protein concentrations in BAL and mRNA expression in the lung of IFNb on days 2, 3, and 5 P.I. were determined by ELISA and qPCR, respectively.
(E) Protein concentrations in lung homogenates and mRNA expression in the lung of IFNa, IL-6, and TNF-a on day 3 P.I. were determined by ELISA and qPCR,
respectively.
(F) IRF3 Ser396 phosphorylation and the expression of PR8 polymerase 2 (PB2) in the lung on day 3 P.I. were determined.
(G) Indicated ISG expression in the lung on day 3 P.I. was analyzed by qPCR.
(H) WT and KO mice (four to five mice in each group) were infected with 50 pfus of PR8 influenza virus. Changes in body weight of WT and KO mice P.I. were
monitored daily.
(I) WT and KO mice (five mice in each group) were infected with 3,000 pfus of PR8 virus with or without daily administration of IFNb neutralizing antibody. The
survival of the mice was monitored for up to 12 days. The data shown are representative of two to three independent experiments with similar results. Data are
presented as mean ± SEM, *p < 0.05, **p < 0.01.NP311-325/IA
b (CD4+ T cells) and DbNP366 (CD8
+ T cells) tetra-
mers. A comparable percentage of antigen-specific CD4+
T cells was observed between WT and KO mice (Figure S1G).
However, the total number of tetramer CD4+ T cells was lower
in the lung fromMKP5 KOmice than that fromWTmice. Further-
more, both the percentage and total cell number of antigen-
specific CD8+ T cells were significantly lower in MKP5 KO (Fig-
ure S1H). Together, these results demonstrate that despite the
reduced influenza-specific T cell responses, MKP5 KO mice
developed less severe disease in response to influenza infection.
To further examine the robust protection observed for MKP5
KO mice against influenza infection, we infected both WT and
KO mice with a lethal dose of PR8 virus. We found that all the
WT mice were dead on day 7 P.I., whereas about 60% of the
KO mice survived (Figure 1I). To address the contribution of1724 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Authorthe enhanced type I IFN response observed in MKP5 KO mice
during influenza infection (Figures 1D and 1E), we administrated
IFNb neutralizing antibody i.n. daily after a lethal dose of PR8 vi-
rus infection in WT and KO. We observed that neutralization of
IFNb resulted in the loss of protection observed in MKP5 KO
mice (Figure 1I), suggesting that the increased IFNb expression
in MKP5 KO mice is important for the increased resistance to
influenza infection.
Increased Type I IFN Expression and IRF3 Activation in
MKP5 KO Macrophages upon Influenza Infection
Type I IFNs play a critical role in inhibiting influenza virus replica-
tion (Garcı´a-Sastre et al., 1998); however, lung epithelial cells are
poor producers of type I IFNs and proinflammatory cytokines in
response to influenza viruses, particularly to NS1-expressings
Figure 2. Increased IRF3 Phosphorylation and Nuclear Translocation in MKP5 KO Macrophages in Response to Influenza Infection
(A) WT and KO BMDMs were infected with PR8 virus for 6 hr. Expression of IFNb, IFNa, IL-6, and TNF-a was determined by qPCR. Cytokine concentrations in
culture supernatants 24-hr P.I. were measured by ELISA. WT and KO BMDMs were infected with PR8 virus at MOI of 2 for the indicated period of time.
(B and C) MAP kinase activation (B) and IRF3 and TBK1 phosphorylation (C) were determined.
(D) BMDMs infected with or without PR8 virus at MOI of 2. Subcellular localization of IRF3 was determined by IRF3 intracellular staining, and confocal fluo-
rescence images were captured. Average nuclear fluorescent intensity (ANFI) of 100 cells was quantified using Image J. Scale bar is 10 mM.
(E) Nuclear fractions from WT and KO BMDMs infected with PR8 virus were isolated to determine IRF3 nuclear accumulation.
(F) WT and KO BMDMs were infected with PR8 virus for 6 hr. The expression of ISG-15, 20-50-oligo (A) synthetase (OAS), RANTES, and viperin was determined
by qPCR.
(G) WT and KO BMDMs were infected with PR8 virus to determine the expression of viperin by western blot and of RANTES by ELISA.
(H) The expression of PR8 non-structure protein 1 (NS1) in WT and KO BMDMs 24h post PR8 infection was determined.
(I) PR8 replication inWT and KOBMDMs at 24-hr P.I. was determined by plaque assay. The data shown are representative of three independent experiments with
similar results. *p < 0.05, **p < 0.01.viruses (Kallfass et al., 2013; Ronni et al., 1997). Macrophages,
on the other hand, are also susceptible to influenza virus infec-
tion (Geiler et al., 2011; Maines et al., 2008) and produce copious
amounts of proinflammatory cytokines and type I IFNs, which are
thought to be the critical determinants for disease severity (Hui
et al., 2009; Kallfass et al., 2013; Michaelis et al., 2009). Thus,
WT and MKP5 KO BMDMs were infected with PR8 virus to
examine the expression of IFNa, IFNb, and proinflammatory cy-
tokines IL-6 and TNF-a. The expression of IFNa and IFNb in KO
macrophages was significantly increased at both the mRNA and
protein level (Figure 2A). The expression of IL-6, but not TNF-a,
was also increased in KO BMDMs upon PR8 infection compared
with WT cells (Figure 2A).CellThe expression of IFNa and IFNb in response to viral infection
is regulated by various transcriptional factors including NF-kB,
IRF3, IRF7, as well as MAPKs (Gonza´lez-Navajas et al., 2012;
Taylor and Mossman, 2013). We found that the activation of
extracellular signal-regulated kinase (ERK) was unchanged at
6- and 9-hr P.I., but that increased ERK activation was observed
in KO cells at 12- and 24-hr P.I. compared with WT cells (Fig-
ure 2B). The activation of p38 in WT and KO cells was compara-
ble (Figure 2B), whereas the activation of JNK was undetectable
upon PR8 virus infection, suggesting that the increased type I
interferon expression observed in MKP5 KO macrophages was
not due to increased activation of MAP kinases. IRF3 plays ama-
jor role in regulation of type I IFN expression in response to viralReports 10, 1722–1734, March 17, 2015 ª2015 The Authors 1725
infection where phosphorylation of Ser396 in IRF3 is a critical
step in IRF3 activation (McCoy et al., 2008; Servant et al.,
2003). We examined the phosphorylation of Ser396 in WT and
MKP5 KO BMDMs in response to PR8 virus infection and found
that the Ser396 phosphorylation was greatly increased at 6-, 9-,
and 12-hr P.I. in KO cells compared with WT cells (Figure 2C).
Phosphorylation of IRF3 is mediated by TBK1 and IKKε (Tamura
et al., 2008). Comparable activation of TBK1 was detected
between WT and KO cells, and phosphorylation of IKKε
was not detectable in both WT and KO cells (Figure 2C). These
results indicated that the increased IRF3 phosphorylation in
MKP5 KO macrophages was not due to increased activation of
TBK1 and IKKε.
Upon phosphorylation, IRF3 translocates into nucleus to
regulate the expression of genes, including IFNa and IFNb. To
examine whether the increased IRF3 phosphorylation observed
inMKP5KOmacrophages leads to increased IRF3 nuclear trans-
location, WT and KO BMDMs with or without PR8 virus infection
were analyzed for IRF3 localizationbymicroscopy.Without infec-
tion, IRF3waspredominantly located in the cytoplasm inbothWT
and MKP5 KO cells (Figure 2D). Upon influenza virus infection,
IRF3 nuclear localization was significantly increased in both WT
and KO cells. Importantly, there was significantly increased
IRF3 nuclear localization in MKP5 KO cells compared with WT
cells after infection (Figure 2D). To substantiate this finding, we
isolated nuclear fractions fromWTandMKP5KOcells at different
time points P.I. to examine IRF3 nuclear accumulation. Signifi-
cantly increased IRF3 nuclear accumulation was observed at
1-, 3-, and 6-hr P.I. in the KO macrophages (Figure 1E). Concor-
dantly, we found increased expression of various ISGs, including
ISG-15,OAS, RANTES/CCL5, and viperin (Figure 2F). In addition,
increasedRANTES/CCL5 and viperin protein expressionwasde-
tected in MKP5 KO cells compared with WT cells (Figure 2G).
Conversely, decreased expression of influenza nonstructure pro-
tein 1 (NS1) and PB2 protein was observed in the KO cells (Fig-
ure 2H), which was accompanied by reduced viral replication in
MKP5 KO cells compared with WT cells (Figure 2I). Together,
these results demonstrated that deficiency of MKP5 in macro-
phages resulted in increased IRF3-type I IFN responses and
reduced influenza virus replication.
Increased Type I IFN Expression and IRF3 Activation in
MKP5 KO DCs upon Influenza Infection
DCs play an important role in anti-influenza virus infection and
also produce both type I IFNs and proinflammatory cytokines
(Waithman and Mintern, 2012). Similar to our findings in macro-
phages, we observed increased expression of IFNa and IFNb
with a further enhancement of TNF-a in MKP5 KO bone
marrow-derived DCs (BMDCs) compared with WT cells in
response to PR8 infection (Figures 3A and 3B). In addition,
increased expression of various ISGs was detected in KO cells
(Figure 3C). Increased IRF3 phosphorylation was detected in
MKP5 KO DCs at 6-, 9-, and 12-hr P.I. (Figure 3D). Activation
of MAP kinases in BMDCs appears to be earlier compared
with that in BMDMs (Figures 2B and 3E). ERK activation in
MKP5 KO DCs in response to PR8 virus infection appeared to
be slightly increased at 2- and 3-hr P.I. compared with that in
WT cells. Interestingly, increased activation of p38 and to a1726 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Authorlesser extent JNK was detected in MKP5 KO DCs compared
withWT cells (Figure 3E). These results suggestedMAPK activa-
tion by MKP5 is in part differentially regulated in macrophages
and DCs during influenza infection.
MKP5 protein is found to be constitutively expressed in human
lung epithelial cell line A549 and PR8 infection increased its
expression (Figure S2A). To further examine the role of MKP5
in regulation of IRF3-type I IFN response, A549 cells overex-
pressing MKP5 were generated (Figure S2B). Upon PR8 infec-
tion, overexpression of MKP5 inhibited IRF3 phosphorylation
and mRNA expression of both IFNa and IFNb (Figures S2B and
S2C). Furthermore, protein expression of IFNb was significantly
lower in MKP5 overexpressing cells compared to that in control
cells (Figure S2D). Together, these results demonstrate that
MKP5 inhibits IRF3 activation and type I IFN expression in lung
epithelial cells in response to influenza infection.
Regulation of Type I IFN Expression in Macrophages by
MKP5 Is Independent of Influenza NS1
NS1 of influenza A virus is a multifunctional viral protein with ac-
tivity that antagonizes type I IFN-mediated antiviral responses
(Hale et al., 2008). To address whether the negative regulation
of type I IFN expression byMKP5 is associated with NS1, murine
macrophages (RAW264.7) were transfected with NS1 genes
from H1N1 and H3N2 influenza viruses. We found that overex-
pression of both H1N1 and H3N2 influenza NS1 genes induced
the expression of MKP5 (Figure S2E). In addition, overexpres-
sion of NS1 in A549 cells induced the expression of MKP5 as
well (Figure S2F). NS1, but not matrix protein 2 (M2) from PR8,
induced both mRNA and protein expression of MKP5 in
RAW264.7 cells (Figures S2G and S2H). Furthermore, PR8 virus
deficient in NS1 (PR8NS1) is impaired in the induction of MKP5
in BMDMs (Figure S2I). Next, we infected WT and MKP5 KO
BMDMs with PR8 or PR8NS1 viruses to examine the expression
of IFNa and IFNb. As expected, PR8NS1 virus infection caused
increases in the expression of IFNa and IFNb in both WT and KO
macrophages compared with cells infected with PR8 virus (Fig-
ure S2J). However, the expression of IFNa and IFNb in MKP5 KO
cells remained higher than those in WT cells upon PR8NS1 virus
infection. Moreover, overexpression of MKP5 in macrophages
inhibited IFNa and IFNb expression in response to PR8NS1 virus
infection (Figure S2K). These results indicate that the inhibition of
MKP5 on type I IFN expression is independent of NS1.
Increased IRF3 Activation and Type I IFN Expression in
MKP5 KOMacrophages upon RIG-I and TLR3 Activation
Influenza virions can be detected by RIG-I (Kato et al., 2006;
Pichlmair et al., 2006). To further understand the regulation of
IRF3 by MKP5, we stimulated WT BMDMs with 50 triphosphate
double-stranded RNA (50ppp-dsRNA), a synthetic ligand for
RIG-I. We found that MKP5 expression was induced in BMDMs
at both the mRNA and protein levels in response to 50ppp-
dsRNA stimulation (Figure 4A). WT and KO BMDMs were then
stimulated with 50ppp-dsRNA to examine IRF3 activation. We
found increased IRF3 phosphorylation in KO cells compared
with WT cells (Figure 4B). Furthermore, MKP5 KO BMDMs had
increased type I IFNs and ISGs compared with WT cells (Figures
4C and 4D).s
Figure 3. Increased Type I IFN Expression and IRF3 Phosphorylation in MKP5 KO DCs
(A and B) WT andMKP5 KO BMDCs were infected with PR8 virus. mRNA and protein expression of IL-6, TNF-a, IL-1b, IFNa, and IFNbwere determined by qPCR
and ELISA, respectively.
(C) WT and KO BMDCs were infected with PR8 virus for 6 hr. ISG expression was examined by qPCR.
(D and E) IRF3 and TBK1 phosphorylation (D) andMAP kinase activation (E) were examined. The data shown are representative of three independent experiments
with similar results. *p < 0.05, **p < 0.01.TLR3 is involved in innate immune response to influenza infec-
tion (Iwasaki and Pillai, 2014). We also found that TLR3 activation
caused by stimulation with poly (I:C) in BMDMs induced the
expression of MKP5 (Figure 4E). MKP5 KO macrophages ex-
hibited increased IRF3 activation (Figure 4F), significantly
increased expression of type I IFNs (Figure 4G) and ISGs (Fig-
ure 4H) in response to TLR3 activation compared with WT cells.
Deficiency of MKP5 Leads to Increased IRF3-Type I IFN
Responses upon VSV and SeV Infection
TLR3 and RIG-I are important in host sensing of viral RNAs.
Thus, to examine the importance of MKP5 in immune responses
to other RNA viruses, we examined the expression of MKP5 in
BMDMs upon VSV and SeV infection. Both VSV and SeV infec-
tion induced the expression of MKP5 (Figures 5A and 5G). Next,
we examined the activation of IRF3 and the expression of type I
IFNs in WT and MKP5 KO BMDMs in response to VSV and SeV
infection. Phosphorylation of IRF3 was detected at 3 hr after
both VSV and SeV infection in WT and KO BMDMs (Figures
5B and 5H). However, IRF3 phosphorylation was found
enhanced by MKP5 KO cells. Moreover, increased expression
of IFNa and IFNb was observed in KO cells compared withCellWT cells (Figures 5C and 5I). In addition, the expression of
ISG-15, PKR, RANTES and viperin was also increased in KO
cells (Figures 5D and 5J). Next, we infected WT and MKP5
KO mice with a sublethal dose of VSV i.n. and serum levels of
IFNb were determined on day 3 P.I. We found increased serum
IFNb in MKP5 KO mice compared with WT mice (Figure 5E).
Significantly less body weight reduction upon VSV infection
was observed in MKP5 KO mice (Figure 5F), suggesting that
the KO mice developed less severe disease. Together, these re-
sults demonstrate that in addition to influenza viruses, other
RNA viruses including VSV and SeV can induce the expression
of MKP5 which in turn suppresses IRF3-mediated type I IFN
responses.
MKP5 Interacts with and Dephosphorylates IRF3
To further understand how MKP5 regulates IRF3 activity, we
examined whether MKP5 directly interacts with IRF3 by trans-
fecting Flag-tagged MKP5 cDNA into RAW264.7 cells for co-
immunoprecipitation. We found that endogenous IRF3 readily
co-immunoprecipitates with MKP5 (Figure 6A). Similar results
were obtained in 293 T cells transfected with both MKP5 and
IRF3 (Figure S3A). We also found that MKP5 interacts withReports 10, 1722–1734, March 17, 2015 ª2015 The Authors 1727
Figure 4. Increased IRF3 Activation and Type I IFN Expression in MKP5 KO Macrophages in Response to RIG-I and TLR3 Stimulation
(A) WT BMDMs were transfected with 50ppp-dsRNA using Lipofectamine LTX reagent (Invitrogen). MKP5 mRNA expression was determined at 6 hr after by
qPCR. MKP5 protein expression was examined.
(B) WT and KO BMDMs were stimulated with 50ppp-dsRNA to examine the activation of IRF3 and TBK1.
(C) mRNA and protein expression of IFNa and INFb after 50ppp-dsRNA stimulation was determined.
(D) mRNA expression of ISGs at 3 hr after 50ppp-dsRNA transfection was analyzed by qPCR.
(E) WT BMDMs were transfected with poly (I:C) to examine MKP5 mRNA and protein expression as in (A).
(F–H) BMDMs were stimulated with poly (I:C) to examine IRF3 and TBK1 activation (F), type I IFN (G), and indicated ISG expression (H).
The data shown are representative of three independent experiments with similar results. *p < 0.05, **p < 0.01.both TBK1 and IKKε (Figure S3B). To substantiate the interaction
between IRF3 and MKP5, we infected RAW264.7 macrophages
with PR8 virus. Anti-IRF3 antibody was used to pull down inter-
acting proteins. As shown in Figure 6B, obvious MKP5 protein
was pulled down at 6-hr P.I., demonstrating that IRF3 interacts
with MKP5 in macrophages in an infection-inducible fashion.
To further validate the interaction between MKP5 and IRF3, we
synthesized mouse MKP5 and IRF3 proteins using wheat em-
bryo extract-mediated cell-free protein synthesis system (Takai
et al., 2010) and performed AlphaScreen assay, a lumines-
cence-based assay (Ullman et al., 1994). Co-incubating MKP5
with IRF3 generated a signal that was far greater than signals
generated from MKP5 incubated with bacterial protein DHFR
or IRF3 incubated with DHFR (Figure 6C), which confirmed the
direct and specific interaction between MKP5 and IRF3.
To further elucidate the interaction between MKP5 and IRF3,
various constructs of MKP5 and IRF3 were generated that incor-
porated deletions of various DNA regions encoding a specific
protein domain/region (Figure S3C). To identify the IRF3-interac-
tion region on MKP5, coimmunoprecipitations of Flag-MKP5
deletion mutants and HA-IRF3 were carried out. Deletion of
N-terminal region NT1 from amino acid 1 to 150 (aa 1–150,
DNT1) slightly decreased the interaction with IRF3 (Figure 6D,1728 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Authorpanel 1, lane 4), while deletion of the C-terminal region (aa
406–483, DCT1), including its catalytic domain (Tanoue et al.,
1999), had no effect (lane 6). Further deletion of the C-terminal
region of MKP5 from aa 406 to aa 290 (DCT2) greatly reduced
its interaction with IRF3 (lane 7), whereas deletion of both the
NT1 and CT2 regions from MKP5 almost completely abrogated
its interaction with IRF3 (lane 10). Conversely, expressing the
NT1 region alone showed aweakened binding to IRF3 compared
with that of WT MKP5 (lanes 8 and 3, respectively). The CT2 re-
gion alone showed greater binding to IRF3 than the full-length
MKP5 (lanes 9 and 3). Collectively, these results demonstrated
a complex 3D interaction whereby two regions in MKP5, the
NT1 and CT2 regions, may be important for its interaction with
IRF3, while the CT2 region plays a dominant role in MKP5
binding to IRF3.
Similarly, to identify the MKP5-interaction region on IRF3, co-
immunoprecipitations of IRF3 mutants and MKP5 were carried
out. The deletion of C-terminal region comprising the IRF asso-
ciation domain (IAD) and tail region (DIAD) or C-terminal region
beyond IAD domain on IRF3 (DTail) completely abolished its
interaction with MKP5 (Figure 6E, panel 1, lanes 5 and 7),
whereas deletion of its DNA binding domain (DBD), nuclear
export signal (NES), PRO domains, or internal deletion of IADs
Figure 5. MKP5 Deficiency Resulted in Increased IRF3 Activation and Type I IFN Responses in Macrophages upon VSV and SeV Infection
(A) WT BMDMs were infected with VSV for 3 hr to examine MKP5 mRNA expression. MKP5 protein expression is at the indicated time points after VSV infection
was determined.
(B) WT and MKP5 KO BMDMs were infected with VSV to examine IRF3 and TBK1 activation.
(C and D) IFNa and IFNb expression (C), as well as the expression of ISGs (D) in WT and KO BMDMs in response to VSV infection were analyzed.
(E) WT and MKP5 KO mice (n = 5) were infected with a sublethal dose of VSV intranasally. Serum levels of IFNb on day 3 P.I. were examined by ELISA.
(F) Changes in body weight of the mice P.I. were monitored daily.
(G) WT BMDMs were infected with SeV for 3 hr to examine MKP5 mRNA expression.
(H–J) IRF3 and TBK1 activation (H), type I IFN expression (I), as well as the expression of the indicated ISGs (J) in WT and KO BMDMs in response to SeV infection
were analyzed.
The data shown are representative of three independent experiments with similar results. *p < 0.05, **p < 0.01.domain (DID-IAD) did not, demonstrating that the tail region of
IRF3 is essential for its interaction with MKP5. In an AlphaScreen
assay, IRF3-DIAD showed similar binding activity to MKP5 as
DHFR, further confirming the essential role of the tail region in
the interaction between IRF3 and MKP5 (Figure 6C).
To test whether MKP5 dephosphorylates IRF3, we prepared
phosphorylated IRF3 and incubated it with recombinant MKP5
or MKP5 phosphatase inactive mutant (MKP5mut) (Zhang et al.,
2004). MKP5, but not MKP5mut, dephosphorylated Ser396 and
Ser386 of IRF3 (Figures 6F and S4A). In addition, we found
that neither MKP5 nor MKP5mut incubated with phosphorylated
TBK1 resulted in dephosphorylation (Figure S4B). Furthermore,
MKP5 inhibited TBK1 overexpression-induced IRF3 phosphory-
lation in 293T cells in a phosphatase activity-dependent manner
(Figure S4C). Therefore, MKP5 dephosphorylates IRF3 at
Ser396 and Ser386, which is dependent on its phosphatase
activity.CellInteraction of MKP5 with IRF3 Is Independent of MAP
Kinases
Consistent with previous findings (Nomura et al., 2012), we found
that MKP5 interacts with ERK, JNK, and p38 (Figure S5A). To
address whether the binding of MKP5 to ERK, p38, and JNK
could affects its interaction with IRF3, we generated MKP5 dele-
tion mutants in which the binding regions of MKP5 for ERK
(MKP5 DERK) or JNK/p38 (MKP5 DJNK/p38) or both (MKP5
DMAPK) (Tanoue et al., 2002; Theodosiou et al., 1999) were
deleted (Figure S3C). These deletion mutants were tested for
their ability to bind IRF3. We found that the deletion of the ERK
binding region (DERK) or the JNK/p38 binding sites (DJNK/
p38) or both (MKP5 DMAPK) from MKP5 abolished its binding
to ERK or JNK/p38, or ERK/JNK/p38, respectively (Figures
S5B, S5C, and 7A). However, these deletion mutants retained
their full ability to bind IRF3 (Figure S5D, panel 1, lanes 3 and
4, and Figure 7A, panel 1, lane 5). Together, these resultsReports 10, 1722–1734, March 17, 2015 ª2015 The Authors 1729
Figure 6. MKP5 Directly Interacts with and Dephosphorylates IRF3
(A) RAW264.7 macrophages were transfected with flag-MKP5. Interaction between MKP5 and endogenous IRF3 was examined by immunoprecipitation (IP).
(B) WT BMDMs were infected with PR8 virus. Cell lysates were precleared with A/G magnetic beads (Pierce) for 1 hr followed by incubation with anti-IRF3
antibody (Cell Signaling) overnight. After incubation, A/G beads were added to pull-down IRF3 interacting proteins followed by western blot analysis to detect
MKP5.
(C) Purified in vitro synthesized MKP5, MKP5 C-terminal deletion mutant (DCT2), IRF3, IRF3 C-terminal mutant (DIAD) proteins were incubated with streptavidin-
coated donor beads or protein A-conjugated acceptor beads (AlphaScreen IgG detection kit, Perkin Elmer) at 16C for 1 hr. Interaction of proteins was analyzed
by an EnSpire Alpha microplate reader (Perkin Elmer).
(D) HEK293T cells transfected with HA-tagged IRF3 together with various MKP5 deletionmutants indicated for IP to examine the ability of theseMKP5mutants to
interact with IRF3.
(E) Lysates from HEK293T expressing Flag-MKP5 together with various HA-tagged IRF3 constructs IP with anti-HA beads were subjected to western blot
analysis to examine their interaction ability with MKP5.
(F) Purified phosphorylated IRF3 was incubated with recombinant MKP5 or MKP5mut in phosphatase assay buffer for 2 hr at 37C. Ser396 level was determined
by western blot analysis. The data shown are representative of three independent experiments with similar results.demonstrate that the interaction of MKP5 with IRF3 is indepen-
dent of its interaction with MAP kinases.
MKP5 Suppresses IRF3 Nuclear Accumulation in
Response to Influenza Infection
To further understand theMKP5-dependent mechanistic regula-
tion of IRF3, we investigated the change in subcellular distribu-
tion of IRF3 in the presence or absence of MKP5 during influenza
infection using confocal microscopy. To this end, we overex-
pressed IRF3 (tagged with mCherry) with or without MKP5
(GFP-tagged) in macrophages. Without influenza infection,
IRF3 was mainly localized in the cytoplasm (Figure S6A),
whereas MKP5 was localized in both cytoplasm and nucleus,
as shown before (Tanoue et al., 1999). Six hours after influenza
infection, substantial localization of IRF3 in the nucleus was1730 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Authorobserved (Figures 7B, panel 3, and S6B). Conversely, cells co-
expressing MKP5 and IRF3 showed substantial reduction in
IRF3 nuclear accumulation compared with cells overexpressing
IRF3 alone (Figures 7B, panel 4, and S6B). In addition, deletion of
MAP kinase binding sites from MKP5 (MKP5DMAPK) did not
impair its ability to retain IRF3 in cytoplasm in response to influ-
enza infection (Figures 7C and S6C), whereas inactivation of
MKP5 phosphatase activity (MKP5mut) or deletion of IRF3-bind-
ing regions from MKP5 (MKP5DNT1/DCT2) resulted in the loss of
retaining IRF3 in cytoplasm (Figure 7C).
To substantiate this result, we co-transfected TBK1/IRF3,
IFNb promoter luciferase construct (IFNb-Luc) together with
MKP5, MKP5mut, or MKP5DNT1/DCT2 into 293T cells to examine
IFNb promoter activities. MKP5 suppressed IFNb transcriptional
activity, and MKP5mut or MKP5DNT1/DCT2 lost the suppressives
Figure 7. MKP5 Suppresses IRF3 Nuclear Accumulation
(A) HEK293T cells were transfected with HA-IRF3 together with either Flag-vector, MKP5, or MKP5DMAPK. Binding ability of MKP5 deletion mutants with IRF3
were examined by IP and western blot.
(B) Raw 264.7 macrophages were transfected with either mCherry-IRF3, GFP-MKP5, or both, along with vector controls and allowed to express the protein of
interest for 20 hr. Samples were processed and analyzed by confocal microscopy following 6-hr virus infection. Scale bar is 10 mM.
(C) Raw 264.7 cells were transfected with mCherry-IRF3 together with WT MKP5, MKP5 phosphatase-deficient mutant (MKP5mut), MKP5 IRF3-binding mutant
(MKP5DNT1/DCT2), orMKP5MAPK-bindingmutant (MKP5DMAPK) followed by infection with PR8NS1 viruses for 6 hr. Subcellular localization ofMKP5 and IRF3was
analyzed by confocal microscopy. Scale bar is 10 mM.
(D) IFNb promoter luciferase construct (IFNb-Luc) was transfected into 293T cells together with indicated plasmids, including WT MKP5, MKP5mut,
MKP5DNT1/DCT2 to examine IFNb promoter activity triggered by TBK1-mediated IRF3 activation using dual-luciferase assay. The data shown are representative of
three independent experiments with similar results.function on IFNb transcriptional activity (Figure 7D). In addition,
macrophages stably overexpressing MKP5 inhibited IRF3 phos-
phorylation and greatly reduced the expression of type I IFNs
(Figures S7A–S7C). Furthermore, the expression of ISG-15,
OAS, and RANTES was also reduced when MKP5 was overex-
pressed (Figure S7D). Protein expression of RANTES by MKP5
overexpressing cells was significantly reduced compared with
control cells as well (Figure S7E). Collectively, these results
demonstrate that MKP5 inhibits type I IFN and other IRF3-target
gene expression in response to influenza virus infection by sup-
pressing IRF3 activation and nuclear accumulation.
DISCUSSION
Targeting type I IFNs is the major mechanism employed by vi-
ruses to evade host immune defense. Viruses have developedCellan impressive diversity of strategies to circumvent the potent
antiviral mechanism mediated by the type I IFN system (Taylor
and Mossman, 2013). Here we demonstrated a type I IFN
evading mechanism by influenza viruses and other RNA viruses
including VSV andSeV through the induction ofMKP5 (DUSP10),
a member of the MKP/DUSP protein family.
Reversible protein phosphorylation regulates almost all as-
pects of cell life where pathogens may exert to evade immunity
by altering the phosphorylation states of host proteins (Cohen,
2001). Phosphatases produced by microbial pathogens play a
key role in pathogenesis (Subramaniam et al., 2013; Viboud
and Bliska, 2005). For instance, the protein tyrosine phospha-
tase YopH from Yersinia can enter human cells causing uncon-
trolled dephosphorylation of many tyrosines to break down
signal transduction mechanisms, which could lead to fatal
outcome of the host (Viboud and Bliska, 2005). On the otherReports 10, 1722–1734, March 17, 2015 ª2015 The Authors 1731
hand, microbial pathogens are able to modulate host protein
kinases and phosphatases to control host responses to their
infection. For example, the oncogenicMarek’s disease virus pro-
duces a bZIP transcription factor, Meq, to activate major kinases
in the ERK pathway and simultaneously to repress phospha-
tases such as PPP2CB and DUSP4 for oncogenesis (Subrama-
niam et al., 2013). MKPs/DUSPs are protein tyrosine phospha-
tases that contain a catalytic domain with significant sequence
similarity to the corresponding region of the protein tyrosine
phosphatase VH-1 from vaccinia virus and are able to dephos-
phorylate both tyrosine and serine/threonine residues within
one substrate (Keyse, 2000). Their function in immune responses
to microbial infection, especially in regulating proinflammatory
cytokine and chemokine expression by controlling MAP kinase
activation, is well documented (Al-Mutairi et al., 2010; Chi
et al., 2006; Zhang et al., 2004; Zhao et al., 2006). The regulation
of IRF3-type I IFNs by MKP5 unveiled in this study represents a
novel function of MKPs/DUSPs in innate immunity. On the other
hand, type I IFNs induced by self-DNA/RNA or microbial infec-
tion have been linked with several autoimmune diseases such
as psoriasis, systemic lupus erythematosus (SLE) and celiac
disease by various mechanisms including promoting the recruit-
ment and activation of inflammatory cells, and facilitating auto-
antibody production (Gonza´lez-Navajas et al., 2012; Tamura
et al., 2008). Therefore, the negative regulation of IRF3-type I
IFNs byMKP5 could be beneficial for the host in type I IFN-medi-
ated immunopathogenesis, which needs to be further clarified.
Our findings on MKP5 induced by RNA viruses to inhibit IRF3-
type I IFNs has thus shed new light on the role of MKPs/DUSPs
in microbial-host interaction.
Recently, a role of protein phosphatase 2A (PP2A) in regula-
tion of IRF3 activation was reported (Long et al., 2014). We
found that in response to influenza infection, MKP5 mRNA
was more highly induced compared with that of PP2A (Fig-
ure S7F). Both PP2A and MKP5 are able to dephosphorylate
phospho (p)-IRF3 (Figure S7G). However, they appear to nega-
tively regulate IRF3 activation by different mechanisms. PP2A
does not directly interact with IRF3 and the adaptor protein
RACK1 is necessary to mediate its interaction with IRF3
(Long et al., 2014). It was proposed that PP2A keeps IRF3 in
an inactive state in cytoplasm during resting and dephosphor-
ylates pIRF3 exported from the nucleus after activation (Long
et al., 2014). These processes are achieved through the forma-
tion of PP2A-RACK1-IRF3 complex. On the other hand, MKP5
expression is induced upon recognition of virus infection. This
protein is evenly distributed in the cytoplasm and the nucleus
where it directly binds to IRF3 (Figures 6 and 7). In addition,
RACK1 binds to the IAD domain of IRF3, whereas MKP5
binds to the tail region outside of the IAD domain at the C ter-
minus of IRF3. Therefore, MKP5 and PP2A could work inde-
pendently or cooperatively in the cytoplasm to control the
activation of IRF3 following virus infection, which will require
further investigation.
NS1 protein of influenza A viruses plays a major role in inhib-
iting type I IFN-mediated antiviral effects through multiple
mechanisms, including limitation of pretranscription of IFNb by
interfering with RIG-I, inhibition of posttranscription of IFNb pro-
duction, and blocking the function of OAS/RNase L and PKR1732 Cell Reports 10, 1722–1734, March 17, 2015 ª2015 The Author(Hale et al., 2008). In this study, we found that NS1 of both
H1N1 and H3N2 influenza viruses expressed in macrophages
induced the expression of MKP5 to suppress the production
of type I IFNs via IRF3. The mechanism on how NS1 induce
the expression of MKP5 is unclear. NS1 contains nuclear local-
ization sequences (NLSs) mediating its binding to importin-a
and rapid nuclear importing (Hale et al., 2008). It is possible
that such nuclear localization can be sensed by the cells which
leads to the induction of MKP5. In addition to importin-a, NS1 is
able to bind to other host proteins, including nucleolin, eIF4GI,
and RIG-I. It is also possible that the binding of NS1 to those
proteins activates unknown mechanisms leading to MKP5
expression. The inhibitory function of MKP5 on IFN production
is independent of NS1 since the PR8NS1 virus induced signifi-
cantly higher levels of type I IFNs from MKP5 KO cells than WT
cells and overexpression of MKP5 in macrophages inhibited
type I IFN expression in response to PR8NS1 virus infection
(Figure S2). Therefore, these findings advance our understand-
ing on the function of NS1 in antagonizing host immune
responses.
MAPKs are the primary substrates of MKPs/DUSPs. However,
proteins other than MAPKs have been identified as substrates of
MKPs/DUSPs. For instance, MKP1 is able to dephosphorylate
histone H3 at Ser10 (Kinney et al., 2009). MKP-3 can dephos-
phorylate FOXO1 at Ser256 to promote its nuclear translocation
(Wu et al., 2010). Here, we found that MKP5 directly interacts
with IRF3 to dephosphorylate Ser396 and Ser386 to inhibit its
activation and subsequent nuclear translocation (Figures 6, 7,
and S4A). Our finding that MKP5 retains IRF3 in cytoplasm in
response to influenza infection (Figures 7 and S6) indicates
that a possible scaffolding function of MKP5 could contribute
to its negative regulation of IRF3, which will be the subject of
future investigation.
It has been shown that ERK and JNK were able to phosphor-
ylate IRF3 at Ser171 and Ser173, respectively (Moore and Petro,
2013; Zhang et al., 2009a). Inhibition of p38 suppressed IFNb
expression in response to H5N1 influenza infection (Bo¨rgeling
et al., 2014). The minimal change of MAP kinase activation
caused by the deficiency of MKP5, together with the direct
MKP5-IRF3 interaction and IRF3 dephosphorylation by MKP5,
leads us to believe that increased IRF3-type I IFN response in
MKP5 KO cells and animals in response to RNA virus infection
is mainly due to direct regulation of IRF3 byMKP5. Nevertheless,
we did not exclude the possible contribution of MAP kinases to
the increased IRF3 activity observed in MKP5 KO cells in this
study.
Finally, we found that the increased innate immune responses
caused by the deficiency of MKP5 resulted in less severe dis-
ease upon influenza virus infection and protected the mice
from influenza lethal infection (Figure 1), despite the reduced an-
tigen-specific CD4+ and CD8+ T cell responses. The reduced
antigen-specific CD4+ and CD8+ T cell responses in MKP5 KO
mice could be due to an intrinsic defect of T cells caused by
MKP5 deficiency as we showed previously (Zhang et al., 2004)
or reduced virus replication due to enhanced type I IFN re-
sponses or both. The function of MKP/DUSP proteins in immune
regulation of RNA viral disease may represent a pathway to be
further explored for therapeutic purposes.s
EXPERIMENTAL PROCEDURES
Mice and Viruses
MKP5 KO mice generated previously (Zhang et al., 2004) were crossed with
C57BL/6 mice for 12 generations. WT and KO pups from the same heterozy-
gous breeders (MKP5+/ 3 MKP5+/) were used to establish the MKP5 WT
and KO colonies and the two colonies were maintained separately. All animals
were housed in ABSL2 conventional clean animal facility. The animal experi-
ments were performed in accordance with the Singapore National Advisory
Committee for Laboratory Animal Research Guidelines. The protocol was re-
viewed and approved by the National University of Singapore Institutional
Animal Care and Use Committee (identification number: 2013-05890).
The influenza virus A H1N1 strain A/Puerto Rico/8/34 (PR8), NS1-deficient
PR8 (PR8-NS1), and the mouse adapted influenza A H3N2 virus strain A/Aichi/
2/68 (Narasaraju et al., 2009) were propagated by allantoic inoculation of
10-day embryonated chicken eggs. Virus titers were determined as PFU on
MDCK monolayers.
Statistical Analysis
Statistical significance was determined using two-tailed Student’s unpaired
t test. Data are presented as mean ± SEM, *p < 0.05, **p < 0.01.
More experimental procedures can be found in Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.02.030.
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